SEC Form 4 insider trading filings tracked in real time from EDGAR

Ben-Noon Alon — Chief Executive Officer

Insider trading activity for Ben-Noon Alon sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Executive Officer
  • Company: NeuroSense Therapeutics Ltd.
  • Total insider trades: 1
  • Total buy volume: $200K
  • Total sell volume: $0
  • Last trade: Jun 17, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Jun 16, 2026 Ben-Noon Alon NRSN NeuroSense Therapeutics Ltd. BUY 250,000 $200K

← All executives · Full trades feed